设为首页
收藏本站
网站地图
|
English
|
公务邮箱
About the library
Background
History
Leadership
Organization
Readers' Guide
Opening Hours
Collections
Help Via Email
Publications
Electronic Information Resources
常用资源
电子图书
期刊论文
学位会议
外文资源
特色专题
内部出版物
CNKI学位论文(31)
知网期刊论文(60)
在“
Elsevier电子期刊
”中,
命中:
24
条,耗时:0.1119458 秒
在所有数据库中总计命中:
91
条
1.
Dipeptidyl peptidase-4 inhibitors and protection against stroke: A systematic re
v
iew and meta-analysis
作者:
F. Barkas
;
M. Elisaf
;
V
.
Tsimihodimos
;
H. Milionis
;
hmilioni@uoi.gr
关键词:
Cerebro
v
ascular
;
Diabetes
;
Dipeptidyl peptidase-4 inhibitors
;
Gliptins
;
Randomized trial
;
Stroke
刊名:Diabetes & Metabolism
出版年:2017
2.
Dipeptidyl peptidase-4 inhibitors and protection against stroke: A systematic re
v
iew and meta-analysis
作者:
F. Barkas
;
M. Elisaf
;
V
.
Tsimihodimos
;
H. Milionis
刊名:Atherosclerosis
出版年:2016
3.
Increased plasma
v
isfatin concentration is a marker of an atherogenic metabolic profile
作者:
T.D. Filippatos
a
;
V
.
Tsimihodimos
a
;
C.S. Derdemezis
a
;
I.F. Gazi
a
;
V
. Saougos
a
;
D.P. Mikhailidis
b
;
A.D. Tselepis
c
;
M.S. Elisaf
a
;
egepi@cc.uoi.gr
关键词:
V
isfatin
;
Cardio
v
ascular risk
;
LDL subclasses
;
HDL subclasses
;
Lipoprotein-associated phospholipase A2
;
Paraoxonase
;
Apolipoprotein C-III
;
Pre-beta1 HDL
刊名:Nutrition, Metabolism and Cardio
v
ascular Diseases
出版年:2013
4.
543 PLASMA
V
ISFATIN CONCENTRATION IS A MARKER OF AN ATHEROGENIC METABOLIC PROFILE
作者:
T. Filippatos
;
V
.
Tsimihodimos
;
C.S. Derdemezis
;
I.F. Gazi
;
V
. Saougos
;
A.D. Tselepis
;
M.S. Elisaf
刊名:Atherosclerosis, Supplements
出版年:2011
5.
Plasma triglyceride le
v
els and body mass index
v
alues are the most important determinants of preβ-1 HDL concentrations in patients with
v
arious types of primary dyslipidemia
作者:
V
asilis
Tsimihodimos
;
Irene Gazi
;
Theodosios Filippatos
;
Michael Kostapanos
;
Kostantinos Lagos
;
Christina Kostara
;
Constantinos C. Tellis
;
Moses Elisaf
;
Alex
;
ros D. Tselepis
关键词:
preβ
;
-1 HDL
;
HDL subfractions
;
Dyslipidemia
;
Metabolic syndrome
刊名:Atherosclerosis
出版年:2010
6.
EFFECT OF EZETIMIBE ON LIPOPROTEIN SUBFRACTION CONCENTRATIONS: THE ROLE OF ATOR
V
ASTATIN PRETREATMENT
作者:
V
.
Tsimihodimos
;
M. Kalogirou
;
K. Lagos
;
A.D. Tselepis
;
M. Elisaf
关键词:
Rare-earth permanent magnet
;
Consolidation
;
Magnetic property
刊名:Atherosclerosis, Supplements
出版年:2008
7.
Abstract: P933 APOLIPOPROTEINS C-II AND C-III AND SMALL DENSE LDL CHOLESTEROL LE
V
ELS IN NON-DIABETIC OBESE SUBJECTS WITH METABOLIC SYNDROME
作者:
T Filippatos
;
V
Tsimihodimos
;
M Kostapanos
;
C Kostara
;
C Tzallas
;
E Bairaktari
;
A Tselepis
;
M Elisaf
刊名:Atherosclerosis, Supplements
出版年:2009
8.
Analysis of 6-month effect of orlistat administration, alone or in combination with fenofibrate, on triglyceride-rich lipoprotein metabolism in o
v
erweight and obese patients with metabolic syndrome
作者:
Theodosios D. Filippatos
;
V
asilis
Tsimihodimos
;
Michael Kostapanos
;
Christina Kostara
;
Eleni T. Bairaktari
;
Dimitrios N. Kiortsis
;
Moses S. Elisaf
关键词:
Apolipoprotein C-II
;
Apolipoprotein C-III
;
Fenofibrate
;
Orlistat
;
Triglycerides
刊名:Journal of Clinical Lipidology
出版年:2008
9.
PO3-85 E
V
ALUATION OF THE ABILITY OF SIMPLE LIPID MEASURES TO PREDICT THE PRESENCE OF SMALL, DENSE LDL PARTICLES
作者:
V
.
Tsimihodimos
;
I. Gazi
;
M. Kalogirou
;
A.D. Tselepis
;
M. Elisaf
刊名:Atherosclerosis, Supplements
出版年:2007
10.
PO23-726 EFFECT OF EZETIMIBE ON LIPOPROTEIN SUBFRACTIONS IN PATIENTS WITH PRIMARY DYSLIPIDEMIAS
作者:
M. Kalogirou
;
V
.
Tsimihodimos
;
I. Gazi
;
C. Kostara
;
A.D. Tselepis
;
M. Elisaf
刊名:Atherosclerosis, Supplements
出版年:2007
1
2
3
按检索点细分(24)
作者(22)
按出版年细分(24)
2017年(1)
2016年(1)
2013年(1)
2011年(1)
2010年(1)
2009年(1)
2008年(2)
2007年(2)
2006年(2)
2005年(2)
2004年(4)
2003年(1)
2001年(4)
2000年(1)
NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via
email
.